1 June 2023
By Allen Young
I am Allen Young.
I’m an Asian-American researcher, inventor, and entrepreneur.
I publicly promote and pursue advancing AI, robotics, humanity longevity biotech, and nuclear-fusion powered outer space tech—according to my plan that I’ve specified and published in my book, The Future, available at Amazon (https://www.amazon.com/dp/B0B1XD1DJJ) and Apple Books (http://books.apple.com/us/book/id6442876664).
I aim to start and build Robocentric, my company that focuses on developing, patenting, productizing, commercializing, and marketing AI tech, robotics tech, humanity longevity biotech, and nuclear-fusion powered outer space tech.
I feel that starting and building Robocentric is an extremely difficult task; I often feel that I’m crazy for pursuing it; yet it’s what I really want to do, so I keep on doing it.
As of now, Robocentric doesn’t have any tech products; Robocentric doesn’t have a revenue; Robocentric isn’t even an incorporated business; Robocentric is a sole proprietorship business with just me striving and struggling to make it take off with its first AI and robotics software products. Even at the earliest, it’ll probably take a couple of years to complete, patent, and launch Robocentric’s first AI and robotics products.
Since in the mid AD 2000’s, in the past 17 years or so, I’ve been developing and documenting Robocentric’s initial AI and robotics software technologies, its other technologies, and its business models. I believe it’s finally the time to complete, patent, and commercialize Robocentric’s first tech products in AI and robotics software. There is no guarantee of technological and financial success, but I believe it is what I must do, so I’ll keep on doing it, as long as God allows me to.
You’re reading this, most likely because you saw one or more of my videos on the social media, and decided to check out my call for accredited Robocentric investors.
If you’re interested in financially supporting my cause of advancing AI, robotics, biotech, and nuclear-fusion tech, as an accredited investor, read on. The following sections present more about Robocentric, its aspirations and goals and plans, and the opportunities to invest in Robocentric as an accredited investor under SEC Regulation D Rule 506(c).
2. Robocentric’s short-term and long-term goals
Robocentric’s short-term goal is—within the next few years or in less than a couple of years—completing, patenting, and launching its first visual AI and robotics software products and business models that Allen Young—the Robocentric founder and CEO, an Asian-American researcher, inventor, and entrepreneur—has been developing for nearly two decades since the mid AD 2000’s.
Robocentric’s multidecadal long-term goal in AI and robotics is creating the AI-powered and robotized American national economy with 360 million factory-worker robots, and 40 million factory-worker-robot manager human workers, in America, and with 500 million service-worker AI units and robots, and 60 million service-worker AI and robot user and manager human workers in America.
Robocentric’s multidecadal long-term goal in biotech is developing and commercializing human longevity biotech, human fertility duration lengthening biotech (especially for women), and human body manufacturing and replacement biotech.
Robocentric’s multicentennial long-term goal in artificial nuclear-fusion powered mass scale outer space humanity expansion tech is building the artificial nuclear-fusion reactors powered Solar System with 10 billion autonomous U.S. military interplanetary spaceships that have artificial nuclear-fusion reactor powered outer space laser cannons, 10 billion civilian interplanetary spaceships in operation at any given time across the Solar System, and over 100 billion human beings living across the Solar System, on or above the Earth-gravity planets (namely, Earth, Venus, Saturn, Uranus, and Neptune)—on Earth, on terraformed Venus land, and in mass-scale outer space human habitats above Saturn, Uranus, and Neptune. Then eventually afterward developing and commercializing interstellar and intergalactic mass-scale outer space humanity expansion technologies.
3. Robocentric funding stages plan
I think, plan, write, and talk (in my social media videos) a lot about Robocentric’s future and growth trajectory.
After reading relevant references, especially the U.S. SEC (Securities and Exchange Commission) documents, I’ve concluded that the following funding and investor-recruitment stages are the most appropriate for Robocentric, with the maximum utilization of the SEC registration exempt security offerings with general solicitation allowance.
- [Pre-product Robocentric funding stage] Self-funding until completing, patenting, and launching the first tech products in AI and robotics software, since Robocentric’s market-success and high-growth potential won’t be palpably demonstrated to potential investors, accredited and non-accredited likewise, until its first AI and robotics tech products are available for purchase, and their patents have been filed by me. (I’ve tried getting seed funding, from prominent U.S. institutions, venture capital firms, and potential angel investors in mid AD 2022; no one wanted to invest, no one; so I chose the route of going self-funding.) However, to practice recruiting and making offers to (accredited) investors, and to prepare for the next stages of Robocentric funding, as allowed by SEC Regulation D Rule 506(c), advertise and solicit getting accredited investors during this stage, with convertible notes as a security offering by a sole proprietorship business (so that general solicitation can be done and practiced as allowed by SEC, even if no convertible notes are sold); this corresponds to the so-called convertible-notes financing stage or seed funding stage for a startup. No Robocentric incorporation yet, in order to not spend and save the incorporation related expenses that should not be spent at this stage, and should be spent on incorporation and patent applications when ready.
- [Post-initial product launch Robocentric funding stage] Immediately after Robocentric incorporation, and patenting and launching the first Robocentric tech products, according to the SEC Regulation D Rule 506(c) (accredited investors only), offer selling private Robocentric shares only to accredited investors by general solicitation and advertisement online.
- [Sufficient early income and profit Robocentric funding stage] When Robocentric generates enough income and profit via selling its first tech products in AI and robotics software licenses and services, make an additional SEC registration exempt security offering according to the SEC Regulation D Rule 504(b) with general solicitation, for making Robocentric private shares offering and sales to non-accredited investors in the most populous U.S. states only (likely California, Texas, and Florida only) with the applicable state fees paid by Robocentric. Robocentric robotics hardware tech development, and early biotech and nuclear-fusion tech R&D will start during this period also, that will be funded by Robocentric’s earliest net incomes.
- [Post-early two years income Robocentric funding stage] After two years of Robocentric company income, with two years of audited Robocentric financial statements filed to SEC via Form C and Form 1 A as required by SEC, Regulation Crowdfunding (Reg CF) and/or Regulation A Tier 2 (Reg A) Robocentric private share offerings to both accredited and non-accredited investors with general solicitation as allowed by SEC. If and as allowed by law, optionally offer (private or non-public) stock buyback; at incorporation, Robocentric bylaws will have clauses on reselling and transfers of private or non-public Robocentric shares that were bought via SEC-registration exempt offerings.
- [Public Robocentric funding stage] Going public. Funding Robocentric via selling Robocentric public shares on one or more public stock exchanges to the maximum extent allowed by SEC regulation. Robocentric intends to go public (i.e. get listed on one or more stock exchanges) when it generates at least several billions of the U.S. dollars in revenue with 20% or higher net profit margin. Robocentric going public may not come for a long time, maybe even over a decade, even if it does go public. Pre-public or private Robocentric investors should expect to hold the Robocentric non-public or private share(s) they purchased for at least a decade.
The above Robocentric funding plan is tentative; it may change according to the evolving circumstances that may include, but are not limited to, SEC regulation change, U.S. state securities law changes, and Robocentric’s financial successes with its tech products.
4. Robocentric ownership structure
Allen Young, the founder and CEO of Robocentric, keeps all the supervoting Robocentric stocks and the controlling voting power in Robocentric indefinitely, likely for multiple decades until he decides that it is time to relinquish the control of Robocentric and hand it to someone else or other people; Allen Young also keeps 35% of the nonsupervoting Robocentric stocks; the rest of the nonsupervoting Robocentric stocks will be distributed to investors and deserving employees over time.
In the future, the supervoting Robocentric stocks will not be paid dividends; the non-supervoting Robocentric stocks may get paid dividends when Robocentric generates sufficient income and profit.
The Robocentric bylaws will have the clauses on the Robocentric stock classes, the Robocentric ownership structure, and the manner of Robocentric control transfer.
Robocentric is currently seeking up to US$350,000 with valuation of US$7 million, with 5% of its non-supervoting stocks up for sale.
5. Worst case scenario
What’s the worst case scenario? What happens if the first Robocentric AI and robotics products fail to get completed, or don’t sell? What happens if Robocentric fails to start making revenue and profit within a reasonable timeframe, say within the next several years? Will I lose the money I invested then? Will some of the money I’ve invested be returned to me in the case of Robocentric’s failure?
First of all, I’ve zero intention and inclination to quit my pursuit of developing and commercializing the AI tech, robotics tech, biotech, and nuclear-fusion powered outer space tech that I envision, have written and published about, and publicly promote on a daily basis on the social media.
So long as my body allows it, I’ll keep on pursuing my vision, as long as I can, even if that means persisting for a few decades before striking my first technology invention and commercialization success.
What you must have as a Robocentric investor is enormous patience on getting a return on your investment—patience that must last well beyond multiple years into multiple decades.
Multidecadal patience and persistence is what I have on building Robocentric; Robocentric investors must have it too.
Second, I’ll keep Robocentric’s spending to the absolute minimum during its current pre-product period. Because the first Robocentric AI and robotics high-tech products will be all software, there will be no expensive initial upfront capital spending to launch those products.
In the unforeseen absolute worst case scenario—of Robocentric making zero profit, spending a substantial portion or all of investors’ monies, and me quitting Robocentric prematurely—which I don’t think would happen, Robocentric would be dissolved, the remaining investor monies would be returned to the investors according to the number of Robocentric shares that each investor bought (i.e. the remaining investor monies would be equally or evenly distributed or returned across the total Robocentric shares sold).
The Robocentric investors will be informed of Robocentric’s ongoing business affairs, especially its spending of its investor monies, via the email addresses on their accounts.
6. Investor risk warning
Investing in a startup company (with no patents and products yet) inherently carries the risk of losing some or all of the money you’ve invested.
Invest in Robocentric, only if you believe in its vision of and commitment to advancing AI, robotics, biotech, and nuclear-fusion tech, and Allen Young’s capability to lead Robocentric to achieve its publicly stated goals and aims.
Invest in Robocentric only if you can afford to lose some or all of the money you invest in Robocentric, to financially protect yourself even in the worst case scenario.
There is no guarantee of return on your investment in Robocentric, even though Allen Young personally guarantees that he will always do his absolute best to make Robocentric a successful corporation that he envisions it will be.
Keep in mind that private placements can be very risky and any investment may be difficult, if not virtually impossible to sell. (Source: https://www.sec.gov/oiea/investor-alerts-bulletins/ib_privateplacements)
Private placements may offer great opportunity. However, the attractive potential rewards often come with high risks of loss. (Source: https://www.sec.gov/oiea/investor-alerts-bulletins/ib_privateplacements)
7. About Robocentric
For more details on Robocentric’s vision of the future that it strives to build by advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech, visit Robocentric.com/About.
8. Contacting Allen Young for potential accredited Robocentric seed funding opportunity
If you’re interested in providing a seed fund to Robocentric as an accredited investor, voice call or send a text message to Allen Young on his Instagram channel (@allenyoungdev, https://instagram.com/allenyoungdev).
9. Authorized capital vs. Issued shares vs. Unissued shares vs. Shares outstanding vs. Treasury stock
The following is basic references on corporate shares or stocks (from Wikipedia).
The authorized capital (https://en.wikipedia.org/wiki/Authorised_capital) of a company (sometimes referred to as the authorized share capital, registered capital or nominal capital, particularly in the United States) is the maximum amount of share capital (https://en.wikipedia.org/wiki/Share_capital) or the maximum number of shares that the company is authorized by its constitutional documents to issue (allocate) to shareholders.
Robocentric’s initial authorized capital, or the maximum number of non-supervoting shares that it can issue is 70,000 shares, with US$100 per share, with US$7,000,000 company valuation.
Issued shares (https://en.wikipedia.org/wiki/Issued_shares) are the shares of a corporation which have been allocated (allotted) and are subsequently held by shareholders and/or the corporation itself.
Initially, all of Robocentric’s supervoting shares are issued to Allen Young, Robocentric founder and CEO.
Initially, 35% of Robocentric’s authorized capital, 24,500 non-supervoting shares are issued to Allen Young, Robocentric founder and CEO.
Robocentric’s issued shares will go up as investors buy Robocentric shares, and as Robocentric issues its shares to its deserving employees.
Unissued shares are the remaining shares of a corporation that can be issued (allocated) to shareholders. The sum of issued and unissued shares equates to the authorized capital of a corporation.
Outstanding shares (https://en.wikipedia.org/wiki/Shares_outstanding) are all the shares of a corporation that have been authorized, issued and purchased by investors and are held by them. They are distinguished from treasury shares, which are shares held by the corporation itself, thus representing no exercisable rights. Shares outstanding (outstanding shares) and treasury shares together amount to the total number of issued shares.
As more investors buy Robocentric shares, Robocentric’s outstanding shares will go up.
A treasury stock (https://en.wikipedia.org/wiki/Treasury_stock) or reacquired stock is stock which is bought back by the issuing company, reducing the amount of outstanding stock on the open market (“open market” including insiders’ holdings). Treasury stock is not entitled to receive a dividend. Treasury stock has no voting rights. Total treasury stock can not exceed the maximum proportion of total capitalization specified by law in the relevant country. When shares are repurchased, they may either be canceled or held for reissue. If not canceled, such shares are referred to as treasury shares. Technically, a repurchased share is a company’s own share that has been bought back after having been issued and fully paid. Treasury shares are essentially the same as unissued capital, which is not classified as an asset on the balance sheet, as an asset should have probable future economic benefits. Treasury shares simply reduce ordinary share capital.
Initially, Robocentric has no treasury shares. Robocentric hasn’t done any share buyback.
10. U.S. SEC references
What are the applicable U.S. SEC (Security Exchange Commission) laws that are applicable to selling private or non-public or non-registered shares of a U.S. corporation such as Robocentric?
Under the federal securities laws, every offer and sale of securities, even if to just one person, must be either registered with the SEC or conducted under an exemption from registration. This is true for companies of all sizes, private and public alike, and includes sales made to anyone, including friends, family, angel investors, and venture capital funds. (Source: https://www.sec.gov/education/capitalraising/building-blocks/sec-have-do-my-private-company)
Generally, a business may not offer or sell securities unless the offering has been registered with the SEC or falls within an exemption from registration. An exempt offering—sometimes referred to as a private offering—is commonly used to describe the offer and sale of securities that is exempt from registration under the Securities Act. Each exemption has specific requirements that a company must meet. (Source: https://www.sec.gov/education/glossary/jargon-z#EO)
SEC-registration exempt offerings overview
Limitations on resale
Regulation S—Rules Governing Offers and Sales Made Outside the United States Without Registration Under the Securities Act of 1933